$ENVA

Enova International, Inc.

2
4
20
$4.5M
Fisher David
100%
See all $ENVA insider activity →
Low

ENVA Maintained by Stephens & Co. -- Price Target Lowered to $20

Stephens & Co. maintained an Overweight rating for Enova International (ENVA) but lowered its price target from $275 to $205. The stock is currently priced at $172.14, which is 17.8% above its GF Value™ of $146.09. Insider activity shows significant selling, with $21.7 million in sales over the past three months. Enova has a GF Score™ of 88/100, indicating strong overall performance but weaker financial strength.

Stephens cuts Enova stock price target to $205 on bank deal withdrawal

Stephens reduced Enova International's (NYSE:ENVA) price target to $205 from $275, citing the withdrawal of its Grasshopper acquisition deal. The stock fell 22.8% to $172.14. Enova reported 35% EPS growth and 30% ROE over two years. Citizens also lowered its target to $215 but maintained an Outperform rating. Enova plans a $500M asset-backed notes offering.

ENVA sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 26 news stories mentioning ENVA (Enova International, Inc.). Coverage has skewed bearish: 2 bullish, 4 neutral, and 20 bearish.

Recent ENVA coverage spans corporate actions, financial news and mergers & acquisitions.

In the last 30 days, ENVA insiders filed 2 SEC Form 4 transactions — no purchases and 2 sales ($4.5M). The most active reporter was Fisher David, Executive Chairman, with 2 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.

What's driving ENVA

AlphAI scores every news story that mentions ENVA with an AI model for sentiment and relevance, and aggregates insider trades from Enova International, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ENVA

Score
$ENVALow

ENVA Maintained by Stephens & Co. -- Price Target Lowered to $20

Stephens & Co. maintained an Overweight rating for Enova International (ENVA) but lowered its price target from $275 to $205. The stock is currently priced at $172.14, which is 17.8% above its GF Value™ of $146.09. Insider activity shows significant selling, with $21.7 million in sales over the past three months. Enova has a GF Score™ of 88/100, indicating strong overall performance but weaker financial strength.

$ENVALow

Jefferies raises Enova International target to $280

Jefferies, TD Cowen, and BTIG analysts raised their price targets for Enova International (ENVA) to $280, $250, and $270 respectively, maintaining Buy ratings. The revisions reflect growing confidence in the company's financial performance and market position, according to the analysts.

$ENVAMedAI 8/10

Enova International subsidiary announces $500 million asset-backed notes offering

Enova International's subsidiary plans a $500M asset-backed notes offering, with four classes of notes ranging from 5.61% to 8.28% interest. The notes are backed by small business loans and expected to be rated by Kroll. Enova reported strong Q2 2026 earnings, exceeding estimates, but withdrew a bank acquisition due to regulatory challenges. Citizens lowered its price target to $215, maintaining an Outperform rating.

$ENVAMedAI 8/10

Enova to issue $500.026M Series 2026-1 asset-backed notes backed by OnDeck loans

Enova plans to issue $500.026M in asset-backed notes due 2026, secured by OnDeck small business loans. The notes, divided into four classes, have fixed rates ranging from 5.61% to 8.28%. KBRA is expected to rate the notes AA(sf) to BB(sf). The proceeds will be used to purchase loans from OnDeck and fund a reserve account. The offering is targeted at qualified institutional buyers under Rule 144A and offshore under Regulation S, with a closing date around September 25, 2026, subject to conditions

$ENVAHighAI 8/10

Why nonbank lender Enova pulled the plug on buying a bank

Enova International (ENVA) withdrew its bid to acquire Grasshopper Bancorp, citing unclear regulatory standards for nonbanks. CEO Steve Cunningham criticized the approval process, stating it lacks clear guidelines. The deal, worth $369M, faced opposition from consumer advocates. Enova's shares dropped 25% on the news.

Related tickers